1. Illustrate the genetic variability of common neuromuscular phenotypes;

2. Delineate optimal, cost effective strategies for diagnosis of genetic muscle diseases;
3. Develop an understanding of genetic therapies for genetic muscle diseases, and understand the translatability of these techniques across the spectrum of disease; and
4. Introduce future paradigms related to management of genetic disorders.


Session date: 
05/03/2018 - 3:00pm to 4:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Matthew P. Wicklund MD